Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Danish pharma; GLP-1 originator (Ozempic 2017, Wegovy 2021). CagriSema (cagrilintide + semaglutide) FDA submission filed December 2025. Diabetes care leader; Novo Holdings acquired Catalent in 2024 to expand fill-finish capacity.
Q2 2016-Q1 2026
Q2 2016-Q1 2026
Q2 2016-Q1 2026